Jeff Bezos said that Washington Post editorial page editor David Shipley decided to resign rather than lead the opinion section under the new policy.
Continue readingCategory Archives: Uncategorized
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.
Continue readingTJ Maxx parent company posts strong holiday, but issues weaker-than-expected guidance
The company behind T.J. Maxx, Marshall’s and Home Goods has seen growth start to slow down, but it’s one of the few retailers that could […]
Continue readingLowe’s beats Wall Street expectations as it starts to break out of sales slump
Lowe’s followed rival Home Depot in reporting better-than-expected quarterly sales.
Continue readingTarget strikes deal with sportswear brand Champion, as it tries to rev up apparel sales
Target has long used brand collaborations to attract shoppers to its stores and website.
Continue readingGM raises quarterly dividend, initiates $6 billion stock buyback
General Motors said Wednesday that it is raising its quarterly dividend and initiating a new $6 billion share repurchase program.
Continue readingDemocrat senators question what Elon Musk plans to do with sensitive CFPB data
Lawmakers questioned whether Elon Musk was conflicted in his moves to dismantle the CFPB, highlighting his recent plan to launch a digital payments service.
Continue readingLucid CEO steps down; EV maker plans to more than double production in 2025
Lucid said Marc Winterhoff, currently the company’s chief operating officer, will step in as interim CEO.
Continue readingHow digitally native companies like Rothy’s are growing profitably in a new era for retail
Flats maker Rothy’s is growing profitably after expanding into wholesale and building its store fleet. In 2024, it saw sales grow 17%.
Continue readingEli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.
Continue reading